We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$353M
AUM Growth
+$63.8M
Cap. Flow
+$52.8M
Cap. Flow %
14.95%
Top 10 Hldgs %
4.83%
Holding
999
New
394
Increased
144
Reduced
103
Closed
356

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$2.27M
2
ORBK
Orbotech Ltd
ORBK
+$1.54M
3
DK icon
Delek US
DK
+$1.53M
4
GLPI icon
Gaming and Leisure Properties
GLPI
+$1.51M
5
MTN icon
Vail Resorts
MTN
+$1.41M

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$1.67M
2
GS icon
Goldman Sachs
GS
+$1.64M
3
DOC icon
Healthpeak Properties
DOC
+$1.5M
4
JPM icon
JPMorgan Chase
JPM
+$1.49M
5
C icon
Citigroup
C
+$1.48M

Sector Composition

Rank Sector Weight
1 Technology 17.04%
2 Consumer Discretionary 14.13%
3 Industrials 12.56%
4 Financials 12.44%
5 Healthcare 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNCR
626
DELISTED
Synchronoss Technologies
SNCR
$166K 0.05%
+1,978
New +$275K
FCX icon
627
Freeport-McMoran
FCX
$89.7B
$163K 0.05%
+11,600
New +$163K
CHS
628
DELISTED
Chicos FAS, Inc.
CHS
$157K 0.04%
+17,500
New +$149K
TISI icon
629
Team
TISI
$77.6M
$154K 0.04%
+1,150
New +$176K
ISBC
630
DELISTED
Investors Bancorp, Inc.
ISBC
$151K 0.04%
11,100
-3,400
-23% -$44.9K
SCMP
631
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$151K 0.04%
+12,800
New +$144K
FOSL icon
632
Fossil Group
FOSL
$241M
$146K 0.04%
15,700
-20,300
-56% -$190K
ARRY
633
DELISTED
Array Biopharma Inc
ARRY
$146K 0.04%
+11,900
New +$111K
ABEV icon
634
Ambev
ABEV
$47.6B
$145K 0.04%
+22,000
New +$136K
KDNY
635
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$127K 0.04%
+2,380
New +$141K
ESV
636
DELISTED
Ensco Rowan plc
ESV
$127K 0.04%
+5,300
New +$106K
SXC icon
637
SunCoke Energy
SXC
$767M
$124K 0.04%
+13,600
New +$128K
AU icon
638
AngloGold Ashanti
AU
$40.5B
$123K 0.03%
+13,200
New +$128K
BCRX icon
639
BioCryst Pharmaceuticals
BCRX
$2.4B
$123K 0.03%
23,400
+700
+3% +$3.58K
P
640
DELISTED
Pandora Media Inc
P
$111K 0.03%
+14,400
New +$124K
KERX
641
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$101K 0.03%
+14,200
New +$102K
IAG icon
642
IAMGOLD
IAG
$8.55B
$73K 0.02%
+11,900
New +$69.1K
VNET
643
VNET Group
VNET
$2.1B
$65K 0.02%
+11,400
New +$56.7K
ACCO icon
644
Acco Brands
ACCO
$370M
– –
-16,700
Closed -$195K
AGNC icon
645
AGNC Investment
AGNC
$12.3B
– –
-18,800
Closed -$400K
AGO icon
646
Assured Guaranty
AGO
$3.79B
– –
-28,000
Closed -$1.17M
AHT
647
Ashford Hospitality Trust
AHT
$20.9M
– –
-15
Closed -$91K
AKBA icon
648
Akebia Therapeutics
AKBA
$327M
– –
-18,800
Closed -$270K
ALB icon
649
Albemarle
ALB
$13.7B
– –
-2,200
Closed -$232K
ALGT icon
650
Allegiant Air
ALGT
$2.65B
– –
-2,100
Closed -$285K
24 25
26
27 28

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q3 2017 Portfolio in Review

As of Q3 2017, Fox Run Management held 999 positions worth $353M, up 22% from $289M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Fox Run Management deployed $52.8M of net new capital in Q3 2017, opening 394 new positions and adding to 144 existing holdings. Its largest new stake was Orbotech Ltd: 40,200 shares worth $1.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Azenta, an estimated $1.33M trimmed.

  • Fox Run Management's largest Q3 2017 buy was Orbotech Ltd: 40,200 shares worth $1.7M.
  • Fox Run Management added most to Philip Morris in Q3 2017, an estimated $2.27M increase.
  • Fox Run Management's biggest Q3 2017 reduction was Azenta, cutting an estimated $1.33M.
  • Fox Run Management fully exited ConocoPhillips in Q3 2017, selling an estimated $1.67M.
  • Fox Run Management's ten largest holdings make up 4.8% of its $353M portfolio in Q3 2017.
  • Fox Run Management opened 394 new positions and closed 356 in Q3 2017.
  • Fox Run Management's portfolio value rose 22% quarter-over-quarter to $353M.

Based on Fox Run Management's 13F filing for Q3 2017, filed 23 Oct 2017.